Vall d’Hebron Institute of Oncology
Vall d'Hebron University Hospital
48 Research physicians
13 Research pharmacists
50Clinical Trial Offices
4Statisticians and database managers
- Phase I Unit (UITM) with all the equipment needed for phase I trials
- Molecular Pathology Laboratory
- Genomics Laboratory
- Proteomics Laboratory
The Vall d'Hebron Institute of Oncology (VHIO) seeks to conduct research of excellence to improve the prevention, early diagnosis and treatment of cancer, especially by developing new cancer-fighting therapies.
The Institute is a biomedical research center located at the Vall d'Hebron University Hospital made up of scientists and doctors working together to bridge the gap between basic science and clinical research. The VHIO has the most advanced equipment and procedures for in-depth analysis of patient tumors.
Within the BioRegion of Catalonia, the VHIO promotes and conducts independent preclinical and translational research of excellence aimed at improving prevention, early diagnosis and treatment of oncological diseases. Furthermore, it strives to be a global benchmark in translational cancer research, with translation as the driving force for all its preclinical and clinical research destined to benefit patients and society as a whole by discovering and promoting new scientific and medical breakthroughs to help fight cancer.
The VHIO was created in 2006 following the model of leading cancer research centers in Europe and the United States.
Areas of clinical expertise
The VHIO’s area of clinical expertise is oncology.
Recognition and distinctions
The VHIO is a CERCA center (Research Centers of Catalonia) and has three ICREA researchers (Dr. J. Arribas, Dr. J. Seoane and Dr. L. Soucek). It is ISO 9001 certified to manage biomedical research projects in oncology (ER-0376/2013) and ISO 15189 certified for Molecular Oncology and Genomics laboratories, under regulation 1052/CE2022 of the Spanish National Accreditation Body (ENAC).
The teaching specialty is medical oncology.